Highly sensitive blood test shows promise for early detection of common deadly cancers

Most cancers become deadly by keeping a low profile, causing no symptoms until they're too advanced to treat. Ovarian and gastroesophageal cancers are among the most notorious for this sly disease progression, often leading to late-stage diagnoses.

Related Keywords

Dana Farber Cancer Institute ,Massachusetts ,United States ,John Lacava ,David Walt ,Megan Craig ,Brigham Biobank ,Martin Taylor ,Rockefeller University Laboratory Of Cellular ,Department Of Pathology At Massachusetts ,Rockefeller University ,Structural Biology ,Mass General Brigham ,Wyss Institute ,Biologically Inspired Engineering ,Harvard University ,Massachusetts General ,Mass General Brigham Biobank ,Blood ,Blood Test ,Essay ,Biomarker ,Biomarker Detection ,Dancer ,Cancer Biomarker ,Fell ,Olorectal ,Iagnostic ,Enetic ,Enome ,Laboratory ,Nanobodies ,Prostate ,Protein ,Eagents ,Research ,